OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Pharmacy and Pharmaceutical Sciences is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy	103
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments	80
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.	42
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs	36
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred	35
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition	35
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines	31
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials	28
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer	26
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs	22
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome	20
Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome	19
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy	18
Dissolution-permeation approach for biopharmaceutical evaluation: a feasibility study using naproxen	17
From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling	16
Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines	16
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System	16
Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin	15
Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis	15
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy	14
Artificial intelligence directed computational protein design: lessons from COVID-19 for pandemic-ready vaccines and antibody therapeutics	13
Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries	13
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System	12
Refined pharmacovigilance assessment of immune checkpoint inhibitors-related bullous pemphigoid: a multi-methodological approach utilizing FAERS database	12
Intrahepatic cholestasis of pregnancy associated with azathioprine: first quantitative disproportionality analysis using the FDA adverse event reporting system	11

Remdesivir-induced conduction abnormalities: A molecular model-based explanation	11
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective	10
Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A	10
Metabolic flux in macrophages in obesity and type-2 diabetes	10
Integration of real-world evidence from different data sources in health technology assessment	9
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis	9
Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients	8
The role of acetylation in obesity-induced cardiac metabolic alterations	8
Formulating biopharmaceuticals using three-dimensional printing	8
A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian	7
Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles	7
Persistence and switching patterns of migraine prophylactic medications in Canada: A retrospective claims analysis comparing adherence and evaluating the economic burden of illness	7
Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database	6
Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database	6
Clinical observation of dexmedetomidine nasal spray in the treatment of sleep disorders on the first night after undergoing maxillofacial surgery: a single-center double-blind randomized controlled st	6
Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients	6
Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (Boswellia spp.): a preliminary in	6
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database	6
Chitosan non-particulate vaccine delivery systems	6
Corrigendum: Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery	5
A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme	5
The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking	5
Weighing in on the role of brown adipose tissue for treatment of obesity	5
Erratum to 'Piecing Together Human Adult Comparative Pharmacokinetic Trials and Rodent Studies: What Happens to Drug Clearance in Obesity?'	4
Zaleplon nanospanlastics loaded transdermal patches: formulation, optimization, ex-vivo permeation, and in-vivo studies	4
Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry	4
A Review of Electronic Cigarettes and Liquid Nicotine Poisoning Exposure Cases in the United States	4
Targeting ketone body metabolism to treat fatty liver disease	3
Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients	3
Rethinking asthma therapy, part 1: transdermal delivery of β2-agonists	3
COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database	3
Film dressings from Thai mango seed kernel extracts versus nanocrystalline silver dressings in antibacterial properties	3
Harnessing DNA polymerase beta defect enhances synthetic lethality and treatment response in gastric cancer cells: implication for immunotherapy	3
Targeted therapy and biomarker-guided applications of ecofriendly silver nanoparticles in precision oncology	3
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis	3